Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Poop pills may stop deadly infections in pancreatitis patients

NCT ID NCT07464392

Prevention Sponsor: Changhai Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether fecal microbiota transplantation (FMT) — transferring gut bacteria from healthy donors — can prevent infections in people with moderately severe or severe acute pancreatitis. About 150 adults will receive either FMT liquid or a placebo through a feeding tube. The goal is to see if FMT reduces serious infections like infected pancreatic necrosis or pneumonia.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fecal microbiota transplantation (FMT) liquid from healthy donors
What this could lead to
If it works, this could offer a new way to prevent life-threatening infections in people with severe pancreatitis.
What could go wrong
This is an early-stage trial with only 150 participants, so results may not apply to everyone. FMT carries a small risk of transmitting infections or causing digestive discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 75 years * Diagnosed with moderately severe acute pancreatitis (MSAP) or severe acute pancreatitis (SAP) according to the Revised Atlanta Classification 2012, with CT severity index (CTSI) score \> 4 * Disease duration of 15 to 21 days * Already have a nasojejunal tube in place * No absolute contraindications to fecal microbiota transplantation * Voluntarily sign the written informed consent form Exclusion Criteria: * Concurrent severe systemic infection * Concurrent extra-intestinal organ infection requiring intervention with broad-spectrum antibiotics * Intestinal obstruction, active gastrointestinal bleeding, intestinal perforation, fulminant colitis, or toxic megacolon * Unable to tolerate enteral nutrition meeting 50% of caloric requirements due to severe diarrhea, significant fibrotic intestinal stricture, severe gastrointestinal bleeding, or high-output intestinal fistula * Pre-existing chronic organ dysfunction (heart, lung, liver, kidney, or hematologic system) prior to admission * Multiple organ dysfunction syndrome (MODS) with a confirmed duration exceeding 2 weeks * Active malignancy * Autoimmune disease or immunocompromised status (including solid organ or bone marrow transplantation, AIDS, long-term use of immunosuppressants or hormones) * Congenital or acquired immunodeficiency * Pregnancy or breastfeeding * Severe mental disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute pancreatitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute pancreatitis Digestive System Diseases pancreas disorder pancreatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute pancreatitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Hospital of Guangdong Medical University

    NOT_YET_RECRUITING

    Zhanjiang, Guangdong, China

  • Changhai Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, China

  • Guangdong Hospital of Traditional Chinese Medicine

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • Guangzhou Medical University Affiliated Panyu Central Hospital

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • Quanzhou First Hospital, Fujian

    NOT_YET_RECRUITING

    Quanzhou, Fujian, China

  • Renji Hospital, Shanghai Jiao Tong University School of Medicine

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

  • Shanghai General Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

  • Shanghai Tenth People's Hospital ,Tenth People's Hospital Affiliated to Tongji University)

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

  • The Affiliated Qingyuan People's Hospital of Guangzhou Medical University

    NOT_YET_RECRUITING

    Qingyuan, Guangdong, China

  • The First Affiliated Hospital of Guangzhou Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine

    NOT_YET_RECRUITING

    Fuzhou, Fujian, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.